ARIEL CAMPBELL: Open Payments
NPI 1841788130 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 8 payments from 7 companies in 2025. Trend: 2023 $1,208 · 2024 $934 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $218 |
| Amgen Inc. | 1 | $146 |
| SANOFI-AVENTIS U.S. LLC | 1 | $133 |
| EVOKE PHARMA, INC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| Janssen Biotech, Inc. | 1 | $102 |
| Dynavax Technologies Corporation | 1 | $98 |
Products named: TZIELD, GIMOTI, BREZTRI, Ozempic, TREMFYA, Heplisav-B.
Industry payments across TX — which companies pay providers there.
